Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants

Journal of Pediatrics

Volumn 144, Issue 3, 2004, Pages 327-332

  Letson, G William ^b   Shapiro, Craig N ^b   Kuehn, Deborah ^b   Gardea, Charlotte ^b   Welty, Thomas K ^b   Krause, David S ^b   Lambert, Stephen B ^b   Margolis, Harold S ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MATERNAL ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; GEOMETRY; HEPATITIS A; HUMAN; IMMUNOGENICITY; INFANT; PRIORITY JOURNAL; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; VACCINATION; VACCINATION REACTION;

EID: 1542406571     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2003.11.030     Document Type: Article

References (30)

1. Centers for Disease Control Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-12):1-38.
2. Centers for Disease Control Prevention. Hepatitis surveillance report no. 57. Atlanta (GA): Centers for Disease Control and Prevention; 2000. p. 38.
3. Shaw FE, Shapiro CN, Welty TK, Dill W, Reddington J, Hadler SC. Hepatitis transmission among the Sioux Indians of South Dakota. Am J Public Health 1990,80:1091-4.
4. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J 1993;12:359-62.
5. McMahon BJ, Williams J, Bulkow L, Snowball M, Wainwright R, Kennedy M, et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J Infect Dis 1995;171:676-9.
6. Balcarek KB, Bagley MR, Pass RF, Schiff ER, Krause DS. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. J Infect Dis 1995;171:S70-2.
7. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992;327:453-73.
8. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328-34.
9. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control and outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996;150:733-9.
10. Averhoff F, Shapiro CN, Bell BP, Hyams I, Burd L, Deladisma A, et al. Control of hepatitis A through routine vaccination of children. JAMA 2001;286:2968-73.
11. Leentvaar-Kuijpers A, Coutinho RA, Brulein V, Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine 1992;10:S138.
12. Wagner G, Lavanchy D, Darioli R, Pecoud A, Brulein V, Safary A, Frei PC. Simultaneous active and passive immunization against hepatitis A studied in a population of travelers. Vaccine 1993;11:1027-32.
13. Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Zur S, et al. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis 1993;168:740-3.
14. Burke DS, Nimmannitya S. Passively acquired antibody to hepatitis A virus in Thai infants. Southeast Asian J Trop Med Public Health 1980;11:415-6.
15. Vargas V, Pedreira JD, Esteban R, Hernandez JM, Guardia J, Bacardi R. Materno-fetal transmission of hepatitis A antibody. Acta Paediatr Scand 1980;69:533.
16. Troisi CL, Hollinger FB, Krause DS, Pickering LK. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules. Vaccine 1997;15:1613-7.
17. Piazza M, Safary A, Vegnente A, Soncini R, Pensati P, Sardo M, et al. Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine 1999;17:585-8.
18. Dagan R, Amir J, Mijalovsky A, Kalmanovitch I, Bar-Yochai A, Thoelen S, et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 2000;19:1045-52.
19. Centers for Disease Control Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1-25.
20. Dean AG, Dean JA, Coulombier D, Burton AH, Brendel KA, Smith DC, et al. Epi Info, version 6: a word-processing, database, and statistics program for public health on IBM-compatible microcomputers. Atlanta (GA): Centers for Disease Control and Prevention; 1994.
21. Schluederberg A, Lamm SH, Landrigan PJ, Black FL. Measles immunity in children vaccinated before one year of age. Am J Epidemiol 1973;97:402-9.
22. Shelton JD, Jacobsen JE, Orenstein WA, Schulz KF, Donnell HD Jr. Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination. Pediatrics 1978;62:961-4.
23. Wilkins J, Wehrle PF. Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization. J Pediatr 1979;94:865-9.
24. Sarvas H, Kurikka S, Seppala IJ, Makela PH, Makela O. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis 1992;165:977-9.
25. Englund JA, Anderson EL, Reed G, Decker MD, Edwards KM, Pichichero ME, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole cell-pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995;96:580-4.
26. Siegrist C-A, Cordova M, Brandt C, Barrios C, Berney M, Tougne C, et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 1998;16:1409-14.
27. Xu Z-Y, Duan S-C, Margolis HS, Purcell RH, Ou-yang P-Y, Coleman PJ, et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. J Infect Dis 1995;171:54-60.
28. Lemon SM. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine. J Hepatol 1993;18(Suppl 2):S15-9.
29. Linder N, Karetnyi Y, Gidony Y, Ohel G, Levin E, Kuint J, et al. Placental transfer of hepatitis A antibodies in full term and preterm infants. Fed Infect Dis J 1997;162:245-7.
30. Fiore AE, Shapiro CN, Sabin K, Labonte K, Darling K, Culver D, et al. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Pediatr Infect Dis J 2003;22:354-9.